Healthcare Industry Updates

Healthcare Industry – Market Size, Investments, Govt Initiatives & Road Ahead
Market Size:
 The Indian healthcare sector is expected to record a three-fold rise, growing at a CAGR of
22% between 2016–2022 to reach US$ 372 billion in 2022 from US$ 110 billion in 2016.
 In the Economic Survey of 2022, India’s public expenditure on healthcare stood at 2.1% of
GDP in 2021-22 against 1.8% in 2020-21 and 1.3% in 2019-20.
 The Indian medical tourism market was valued at US$ 2.89 billion in 2020 and is expected to
reach US$ 13.42 billion by 2026.
 The e-health market size is estimated to reach US$ 10.6 billion by 2025.
 As of January 2022, the number of medical colleges in India stood at 595.
Investments/Developments:
 Between April 2000-December 2021, FDI inflows for drugs and pharmaceuticals sector stood
at US$ 19.19 billion, according to the data released by Department for Promotion of Industry
and Internal Trade (DPIIT). FDI inflows in sectors such as hospitals and diagnostic centres
and medical and surgical appliances stood at US$ 7.73 billion and US$ 2.35 billion,
respectively.
 India currently holds the fourth position in attracting VC funding to the health-tech sector,
with investments of US$ 4.4 billion between 2016 and 2021, with US$ 1.9 invested in 2021
alone.
 The number of policies issued to women in FY21 stood at 93 lakh, with one out of every three
life insurance policies in FY21 sold to a woman.
Govt Initiatives:
 In the Union Budget 2022-23:

o Rs. 86,200.65 crore (US$ 11.28 billion) was allocated to the Ministry of Health and
Family Welfare (MoHFW).
o Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) was allocated Rs. 10,000 crore
(US$ 1.31 billion)
o Human Resources for Health and Medical Education was allotted Rs. 7,500 crore
(US$ 982.91 million).
o National Health Mission was allotted Rs. 37,000 crore (US$ 4.84 billion).
o Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) was allotted
Rs. 6,412 crore (US$ 840.32 million).
o The Government of India approved continuation of ‘National Health Mission’ with a
budget of Rs. 37,000 crore (US$ 4.85 billion).
o Rs. 5,156 crore (US$ 675.72 million) was allocated to the newly announced PM-
ABHIM to strengthen India’s health infrastructure and improve the country’s
primary, secondary and tertiary care services.
 As of April 5, 2022, 117,771 Ayushman Bharat-Health and Wellness Centres (AB-HWCs)
are operational in India. Also as on even date, 748 e-Hospitals were established across India
as part of the central government's ‘Digital India’ initiative.
 According to a spokesperson, the Indian government is planning to introduce a credit
incentive programme worth Rs. 500 billion (US$ 6.8 billion) to boost the country’s healthcare
infrastructure. The programme will allow firms to leverage the fund to expand hospital
capacity or medical supplies with the government acting as a guarantor and strengthen
COVID-19-related health infrastructure in smaller towns.
Road Ahead:
 India’s healthcare sector is much diversified and is full of opportunities in every segment,
which includes providers, payers, and medical technology. With the increase in the
competition, businesses are looking to explore the latest dynamics and trends which will have
a positive impact on their business.
 The hospital industry in India is forecast to increase to Rs. 8.6 trillion (US$ 132.84 billion) by
FY22 from Rs. 4 trillion (US$ 61.79 billion) in FY17 at a CAGR of 16–17%.
 The Government of India is planning to increase public health spending to 2.5% of the
country's GDP by 2025.
 India's competitive advantage also lies in the increased success rate of Indian companies in
getting Abbreviated New Drug Application (ANDA) approvals. India also offers vast
opportunities in R&D as well as medical tourism. To sum up, there are vast opportunities for
investment in healthcare infrastructure in both urban and rural India.
To Whomsoever It May Concern
Healthways Milk Product Pvt Ltd is a Private Limited company registered under Companies Act,
2013 and has following Directors as its shareholders:
Name Designation Shareholding %

Mr. Narendra Nagar Director 99.90%
Mrs. Seema Nagar Director 0.10%
It may further be noted that basis our knowledge & understanding and opinions available with us, for
the purposes of evaluating compliance of conditions under Section 185 (3) of Companies Act, 2013
i.e. exemptions on a Pvt Ltd Company for extending a Corporate Guarantee/Loan to its Directors, it
may be stated that as on June 30, 2022, Healthways Milk Product Pvt Ltd is in compliance of the 3
conditions as outlined in said section. Accordingly, Healthways Milk Product Pvt Ltd can extend a
Corporate Guarantee/Loan to its Directors as of even date.
This certificate is intended to be issued for the purposes of proposed loan transaction of Mr. Narendra
Nagar and cannot be used for any other purpose whatsoever.
For & On Behalf of Healthways Milk Product Pvt Ltd
*Name of Company Secretary*

Company Secretary
Date: 29.07.2022
Place: New Delhi

Healthcare Industry Updates

Uploaded by

Copyright:

Available Formats

Healthcare Industry Updates

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Healthcare Industry Updates

Uploaded by

Copyright:

Available Formats

Healthcare Industry – Market Size, Investments, Govt Initiatives & Road Ahead

 In the Union Budget 2022-23:

Name Designation Shareholding %

For & On Behalf of Healthways Milk Product Pvt Ltd

Name of Company Secretary

You might also like